share_log

Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $32 Price Target

Moomoo 24/7 ·  Apr 9 06:28

Needham analyst Ami Fadia reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and maintains $32 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment